Ib Groth Clausen

Head Of New Modalities and Drug Delivery at Novo Nordisk

Ib Groth Clausen has a strong background in bioinformatics, computational biology, and scientific research with extensive experience at companies such as Novo Nordisk, AstraZeneca, and Prevas. Ib Groth has held various leadership positions, including Principal Scientist and Department Manager, contributing significantly to target discovery, biomarker discovery, and drug delivery. Ib has a Master's degree in Chemical Engineering from DTU - Technical University of Denmark and a solid educational background from Skovgårdsskolen.

Links

Timeline

  • Head Of New Modalities and Drug Delivery

    February, 2023 - present

  • Principal Scientist

    September, 2018

  • Department Manager

    September, 2016

View in org chart